169251 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing; Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses; Viruses HIV or HTLV
IMMUNOASSAY APPARATUS AND IMMUNOASSAY METHOD
#302Heteroduplex tracking assay
#303HIV VPR-specific T cell receptors
#304MOLECULARLY IMPRINTED POLYMERS FOR DETECTING HIV-1
#305COMPOSITIONS AND METHODS FOR DETECTING AND TREATING HIV INFECTIONS
#306Methods for Detecting Metabolic States by Laser Ablation Electrospray Ionization Mass Spectrometry
#307HOMOGENEOUS TIME RESOLVED FLUORESCENCE BASED TEST SYSTEM
#308Assay device and method
#309CONSTRAINED HIV V3 LOOP PEPTIDES AS NOVEL IMMUNOGENS AND RECEPTOR ANTAGONISTS
#310Test method on feline vaccinated with feline immunodeficiency virus vaccine, and antigen for use in the test
#311METHOD FOR DETERMINING ONE OF THE TWO HUMAN IMMUNODEFICIENCY VIRUS (HIV) INTEGRASE ENZYMATIC ACTIVITIES
#312REAGENT FOR DETECTING HIV-1 ANTIGEN AND DETECTION METHOD
#313Synthetic peptide vaccines for HIV: the CBD epitope as an effective immunogen to elicit broadly neutralizing antibodies against HIV
#314Methods of inhibiting viral replication and improving T cell function employing soluble Tim-3 inhibitors
#315Assays And Kits For Determining HIV-1 Tropism
#316ANALYTE MANIPULATION AND DETECTION
#317Multiple antigenic peptide assay for detection of HIV or SIV type retroviruses
#318METHOD OF MONITORING HIV INFECTION
#319Diagnostic Methods for HIV Infection
#320Assay method for peptide specific T-cells
#321NOVEL ADIPOCYTOKINE VISFATIN/PBEF1 IS AN APOPTOSIS ASSOCIATED FACTOR INDUCED IN MONOCYTES DURING IN VIVO HIV-1 INFECTION
#322Non-M, non-O HIV-1 strains, fragments and uses
#323VPR FUNCTION AND ACTIVITY
#324Dual path immunoassay device
#325MUTATIONAL PROFILE IN HIV-1 GAG CLEAVAGE SITE CORRELATED WITH PHENOTYPIC DRUG RESISTANCE
#326Compositions and methods for determining whether a subject would benefit from co-receptor inhibitor therapy
#327PROTEINS FOR USE IN DIAGNOSING AND TREATING INFECTION AND DISEASE
#328Monitoring and inhibiting human immunodeficiency virus infection by modulating HMGB1 dependent triggering of HIV-1 replication and persistence
#329ANTI-HIV IMMUNOGENIC FORMULATION AND PROCESS FOR PREPARATION THEREOF
#330Detection of HIV-related proteins in urine
#331Crystal structure of the catalytic domain of the viral restriction factor APOBEC3G
#332Method of inhibiting HIV replication utilizing the P7 nucleocapsid protein
#333Identification of therapeutic agents for HIV infection
#334METHOD FOR DETECTION OF HUMAN IMMUNODEFICIENCY VIRUS
#335Method for screening anti-HIV Drugs and a diagnostic method of AIDS
#336Alpha1 proteinase inhibitor peptides methods and use
#337Tetramers
#338METHODS TO IDENTIFY POLYNUCLEOTIDE AND POLYPEPTIDE SEQUENCES WHICH MAY BE ASSOCIATED WITH PHYSIOLOGICAL AND MEDICAL CONDITIONS
#339Method for inducing cross-reactive immune responses to the human immunodeficiency virus (HIV) in a host by administering feline immunodeficiency virus (FIV) capsid (CA) or reverse transcriptase (RT) immunogens
#340Influenza virus inhibiting peptides
#341Modified HIV-1 group M cyclic gp41 peptides and their use in the detection of anti-HIV-1 antibodies
#342Multi-subtype FIV vaccines
#343METHOD FOR DIAGNOSING AND MONITORING CELLULAR RESERVOIRS OF DISEASE
#344Semi-quantitative immunochromatographic device and method for the determination of HIV/AIDS immune-status via measurement of soluble CD40 Ligand/CD154, A CD4+ T cell equivalent and the simultaneous detection of HIV infection via HIV antibody detection
#345METHODS AND COMPOSITIONS FOR INHIBITING HIV INFECTION
#346Method for the identification of human immunodeficiency virus related antibodies in blood
#347METHODS AND COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION
#348Use of Intramolecularly, Covalently Cross-Linked Proteins As Binding Partners In Immunoassays
#349Method to measure and characterize microvesicles in the human body fluids
#350Antibody or a fragment thereof, having neutralizing activity against HIV
#351Rapid test for detecting infection
#352Methods of Detecting Inhibitors of VIF-Mediated APOBEC3G Degradation and HIV
#353Simian tropic, recombinant human immunodeficiency-1 viruses
#354Three-dimensional structure of the APOBEC 2 structure, uses thereof, and methods for treating chronic and infectious diseases
#355Fluorescence resonance energy transfer screening assay for the identification of HIV-1 envelope glycoprotein-medicated cell
#356POLYPEPTIDE DERIVED FROM gp41, A VACCINE COMPOSITION COMPRISING SAID POLYPEPTIDE, AND USES FOR TREATING AN INFECTION BY AN HIV VIRUS IN AN INDIVIDUAL
#357High Affinity Nucleic Acid Ligands To Lectins
#358Analysis of HIV-1 coreceptor use in the clinical care of HIV-1-infected patients
#359Purified antibody to the extracellular domain of NKp44L
#360Semi-quantitative immunochromatographic device and method for the determination of HIV/AIDS immune-status via measurement of soluble CD40 ligand/CD 154, A CD4+T cell equivalent
#361Methods for determining human immunodeficiency virus type 2 (HIV-2) protease sensitivity or resistance to antivirals utilizing an inducible yeast expression system
#362Virus coat protein/receptor chimeras and methods of use
#363IMMUNOASSAYS, HAPTENS, IMMUNOGENS AND ANTIBODIES FOR ANTI-HIV THERAPEUTICS
#364Heteroduplex tracking assay
#365ANALYSIS OF HIV-1 CORECEPTOR USE IN THE CLINICAL CARE OF HIV-1 INFECTED PATIENTS
#366Methods for producing fusion polypeptides or enhancing expression of fusion polypeptides
#367Methods for the detection of HIV-1 antibodies employing polypeptides obtained from gag P6 protein
#368Compounds that inhibit HIV particle formation
#369Monoclonal antibodies to HIV-1 and methods of using same
#370Immunoglobin IgG3 as a marker for protecting against infectious viral diseases, and the uses of the same
#371Assays for Detecting Hiv-1 Tat Protein in Hiv-1 Infection
#372Nucleotide sequences of HIV-1 group (or subgroup) O retroviral antigens
#373Lateral-Flow Test Device Providing Improved Test Result Validity
#374Method for simultaneously detecting an antigen of, and an antibody against, an infectious microorganism
#375Inhibition of HIV-1 Replication by Disruption of the Processing of the Viral Capsid-Spacer Peptide 1 Protein
#376ANALYSIS OF HIV-1 CORECEPTOR USE IN THE CLINICAL CARE OF HIV-1-INFECTED PATIENTS
#377Method of inhibiting lentiviral infectivity utilizing zinc chelation to inhibit Vif activity
#378Constrained Hiv V3 Loop Peptides as Novel Immunogens and Receptor Antagonists
#379Inhibition of Hiv-1 Replication by Disruption of the Processing of the Viral Capsid-Spacer Peptide 1 Protein
#380Method for preventing HIV-1 infection of CD4 cells
#381Tat-based immunomodulatory compositions and methods of their discovery and use
#382Multi-subtype FIV vaccines
#383CCR5 chemokine receptor-specific monoclonal antibodies capable of inhibiting HIV-1 cell fusion
#384Use of intramolecularly, covalently cross-linked proteins as binding partners in immunoassays
#385Method for treatment of HIV infection
#386Detecting early HIV infection in genital tract cells and secretions
#387Analysis of HIV-1 coreceptor use in the clinical care of HIV-1-infected patients
#388Molecular scaffolds for HIV-1 epitopes
#389Compositions and methods for detecting and treating HIV infections
#390Interacting site for gp41 on gp120 of hiv-1
#391Diagnostic reagent and diagnostic reagent kit for HIV infection, method for manufacturing diagnostic reagent for HIV infection and method for detecting anti-HIV antibody
#392Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS
#393Heteroduplex tracking assay
#394Assay device and method
#395Use of intramolecularly, covalently cross-linked proteins as binding partners in immunoassays
#396Retrovirus from the HIV group and its use
#397DETERMINATION METHOD AND DETERMINATION KIT
#398Human antibodies interacting with HIV gp41
#399Quinolin-4-ones as inhibitors of retroviral integrase for the treatment of HIV, AIDS and AIDS related complex (ARC)
#400Arrays with cleavable linkers
#401Arrays with cleavable linkers
#402Method Of Therapy
#403Non-M, non-O HIV-1 strains, fragments and uses
#404Native analyte as a reference in lateral flow assays
#405Dual path immunoassay device
#406IMMUNOASSAY FOR HIV PROTEASE INHIBITORS
#407PLATE, DETERMINATION KIT, AND DETERMINATION METHOD FOR IMMUNOASSAY
#408Hiv-dependent expression constructs and uses therefor
#409Retrovirus from the HIV group and its use
#410HUMAN IMMUNODEFICIENCY VIRUS ENTRY INHIBITOR ASSAY
#411Polypeptide derived from gp41, a vaccine composition comprising said polypeptide, and uses for treating an infection by an hiv virus in an individual
#412Methods for assaying inhibition of HIV-1 envelope glycoprotein-mediated membrane fusion
#413Method for the detection of newly acquired hiv infection
#414Methods and compositions for treatment of tumors using nucleic acid ligands to platelet-derived growth factor
#415METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF VIRAL AND BACTERIAL INFECTIONS
#416Biomarkers of resistance to infections in humans and biological applications thereof
#417Time-of-addition assay for identifying anti-viral compounds
#418Methods and compositions for inhibiting HIV infection
#419Influenza virus inhibiting peptides
#420PROCESS FOR THE DETERMINATION OF PEPTIDES CORRESPONDING TO IMMUNOLOGICALLY IMPORTANT EPITOPES AND THEIR USE IN A PROCESS FOR DETERMINATION OF ANTIBODIES OR BIOTINYLATED PEPTIDES CORRESPONDING TO IMMUNOLOGICALLY IMPORTANT EPITOPES, A PROCESS FOR PREPARING THEM AND COMPOSITIONS CONTAINING THEM
#421Method for the in vitro assessment of the progression status of an infection by an hiv virus in an individual
#422Method for monitoring anti-HIV treatment in HIV infected individuals
#423P38 kinase inhibitor compositions and methods of using the same
#424Interacting polypeptide comprising a heptapeptide pattern and a cellular penetration domain
#425ANTI-HIV IMMUNOGENIC FORMULATION AND PROCESS FOR PREPARATION THEREOF
#426Microchip-based system for hiv diagnostics
#427Novel mechanism for hiv-1 entry into host cells and peptides inhibiting this mechanism
#428Peptides for the detection of HIV-1 group O
#429Method of screening compounds which inhibit the initiation of the retrotranscription of the rna of virus hiv-1 and means for implementing same
#430Dual path immunoassay device
#431Methods for diagnosing htlv-i-mediated diseases
#432Heteroduplex tracking assay
#433Multiple antigenic peptide assay for detection of hiv or siv type retroviruses
#434Methods for assaying inhibition of HIV-1 envelope glycoprotein-mediated membrane fusion
#435Method for treatment of HIV infection
#436Immunoassay for HIV protease inhibitors
#437Methods and compositions, relating to hiv gp41 antigens and other hiv envelope antigens
#438Identification of new CD8 epitopes from HIV-1 proteins
#439Tenascin-C nucleic acid ligands
#440Diagnostic assays
#441Systematic evolution of ligands by exponential enrichment: Chemi-SELEX
#442Functional fragments of HIV-1 VPR protein and methods of using the same
#443High affinity TGFbeta nucleic acid ligands and inhibitors
#444Immunoassay for HIV protease inhibitors
#445Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS
#446Method for preventing HIV-1 infection of CD4+ cells
#447HIV antisense proteins
#448Assay for TSG101 as inhibitors of HIV production
#449HIV antisense proteins
#450Methods and compositions for impairing multiplication of HIV-1
#451Assay system for screening protease inhibitors
#452Immunoassays, haptens, immunogens and antibodies for anti-HIV therapeutics
#453Methods and reagents for identifying inhibitors of viral protease activity
#454Virus coat protein/receptor chimeras and method of use
#455Functional inactivation of cxcr4-mediated responses in growth hormone transgenic mice through socs53 upregulation
#456Compositions and methods for determining the replication capacity of a pathogenic virus
#457Compositions and methods for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recombinant virus assays
#458Anti-fusion assay
#459Peptides that bind to broadly neutralizing anti-HIV antibody-structure of 4E10 Fab fragment complex. uses thereof, compositions therefrom
#460Tat-based immunomodulatory compositions and methods for their discovery and use
#461Non-pathogenic strains of HIV-1
#462Soluble complex comprising a retroviral surface glycoprotein
#463Enhancing anti-HIV efficiency through multivalent inhibitors targeting oligomeric gp120
#464Nucleic acid ligand complexes
#465CD8 epitope from HIV-1 protein Vpu
#466Monoclonal antibodies and their use
#467Methods for determinging the influence of protein binding on antiretroviral activity
#468Immunoglobulin IgG3 as a marker for protecting against infectious viral diseases, and the uses of the same
#469Truncation SELEX method
#470Synthetic peptide vaccines for HIV: the CBD epitope as an effective immunogen to elicit broadly neutralizing antibodies against HIV
#471Single cell assessment of viral infection/replication
#472Soluble complexes of amylod β peptide and peptidyl prolyl isomerase chaperone and methods of making and using them
#473Inhibition of retroviral replication through modulation of the host cell ubiquitylation
#474Cytidine deaminase activators, deoxycytidine deaminase activators, Vif antagonists, and methods of screening for molecules thereof
#475Zinc finger protein derivatives and methods therefor
#476Method and device for detecting feline immunodeficiency virus
#477Method and device for detecting feline immunodeficiency virus
#478Retrovirus from the HIV group and its use
#479Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them
#480High affinity RNA ligands of basic fibroblast growth factor
#481Cell-based method and assay for measuring the infectivity and drug sensitivity of immunodeficiency virus
#482Anti-retroviral analysis by mass spectrometry
#483HIV-specific T-cell induction
#484HIV-1 VPR interactions with mitochondrial apoptosis inducing factor and methods of using the same
#485HIV-1 envelope glycoproteins having unusual disulfide structure
#486Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein
#487TSG101 as inhibitor of HIV production
#488In vitro assays for inhibitors of hiv capsid conformational changes and for hiv capsid formation
#489Domain-exchanged binding molecules, methods of use and methods of production
#490Methods for improving analyte detection using photochemical reactions
#491Methods for improving analyte detection using photochemical reactions
#492HIV antisense proteins